Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  by Kallies, Axel et al.
Immunity
ArticleBlimp-1 Transcription Factor Is Required
for the Differentiation
of Effector CD8+ T Cells and Memory Responses
Axel Kallies,1,* Annie Xin,1,2 Gabrielle T. Belz,1,3 and Stephen L. Nutt1,3,*
1The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia
2The Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia
3These authors contributed equally to this work
*Correspondence: kallies@wehi.edu.au (A.K.), nutt@wehi.edu.au (S.L.N.)
DOI 10.1016/j.immuni.2009.06.021SUMMARY
In response to viral infection, naiveCD8+Tcells prolif-
erate and differentiate into cytotoxic and cytokine-
producing effector cells. Here we showed that the
transcription factor Blimp-1, a crucial regulator of
plasma cell differentiation, was required for CD8+
T cells to differentiate into functional killer T cells in
response to influenza virus.Blimp-1wasnot essential
for the generation of memory T cells but was crucial
for their efficient recall response upon reinfection.
Antigen-specificBlimp-1-deficientCD8+T cells failed
to appropriately regulate the transcriptional program
essential for killer T cell responses and showed
impaired migration to the site of infection. This study
identifies Blimp-1 as a master regulator of the
terminal differentiation of CD8+ effector T cells and
uncovers a conservation of the pathways that regu-
late the terminal differentiation of T and B cells.
INTRODUCTION
CD8+ T cells are critical for protective immunity against intracel-
lular pathogens such as viruses. During a viral infection, naive
CD8+ T cells respond to antigen by undergoing a pronounced
clonal expansion during which a large number of antigen-
specific T cells is generated (Williams and Bevan, 2007). These
cells display a wide range of effector functions such as cytotox-
icity and cytokine secretion. This initial expansion and acquisi-
tion of effector functions is followed by a contraction phase
where the majority of the reactive CD8+ T cells undergo pro-
grammed cell death, leaving behind a small population of
memory cells. Memory CD8+ T cells can, in response to antigen
re-encounter, rapidly generate large numbers of effector cells
(Sprent and Surh, 2002). This enhanced secondary response
can be attributed partly to the increased precursor frequency
of antigen-specific cells but also to a qualitatively altered respon-
siveness of the memory CD8+ T cells themselves, a process
sometimes referred to as ‘‘memory programming’’ (Masopust
et al., 2004). This programming depends on CD4+ T cell help
and interleukin-2 (IL-2), because memory CD8+ T cells that are
generated in the absence of MHCII or IL-2 signaling are stronglyimpaired in their ability to functionally respond to a subsequent
challenge (reviewed in Williams and Bevan, 2007).
Although multiple models have been proposed to account for
the coordinated production of effector andmemoryCD8+ T cells,
the factors that control this differentiation process are poorly
understood (Joshi and Kaech, 2008; Masopust et al., 2004; Wil-
liams and Bevan, 2007). Recent evidence suggests that memory
precursor T cells as well as effector T cells that lack memory
potential can be identified early during an antiviral immune
response (Joshi et al., 2007). This study concluded that the
degree of inflammation and the resulting induction of distinct
amounts of the T box transcription factor T-bet controlled
effector and memory cell fate decisions, because high levels of
inflammation and T-bet promoted effector cell differentiation,
whereas mild inflammation and low T-bet generated memory
cells (Joshi et al., 2007). Another T box factor, Eomesodermin
(Eomes), is expressed in a reciprocal manner to T-bet, because
it is repressed by inflammatory cytokines such as IL-12 (Take-
moto et al., 2006) and is proposed to promote memory formation
(Intlekofer et al., 2005). Although both T-bet and Eomes are
singularly dispensable for effector functions, genetic evidence
suggests that they redundantly function to promote both the
killer T cell fate and CD8+ memory homeostasis (Intlekofer
et al., 2005, 2008).
The B lymphocyte-induced maturation protein 1 (Blimp-1), en-
coded by the Prdm1 gene, is a transcriptional repressor that is
essential for the differentiation of plasma cells (Martins and Cal-
ame, 2008; Nutt et al., 2007). Blimp-1 is also required for the
development of multiple cell lineages during embryogenesis
(Horsley et al., 2006; Ohinata et al., 2005; Robertson et al.,
2007), the differentiation of skin keratinocytes (Magnusdottir
et al., 2007), and the maintenance of T cell homeostasis (Kallies
et al., 2006; Martins et al., 2006). Mice with a T cell-specific dele-
tion of Blimp-1 or mice reconstituted with Blimp-1-deficient fetal
liver cells show a pronounced accumulation of antigen-experi-
enced T cells and develop severe T cell-mediated immune
pathology (Kallies et al., 2006; Martins et al., 2006). Subsequent
studies revealed that Blimp-1 is induced by IL-2 and represses
Il2 transcription in a negative feedback loop (Martins et al.,
2008; Gong and Malek, 2007; Santer-Nanan et al., 2006). The
function of Blimp-1 in T cell differentiation and its role in T cell
responses in vivo, however, have not been addressed.
Here we have investigated the role of Blimp-1 in CD8+ T cells
during an immune response to influenza virus. We showed thatImmunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 283
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succumb to viral infection. Blimp-1-deficient CD8+ T cells failed
to activate the effector T cell transcriptional program and
showed impaired cytotoxicity and homing to the lung. Blimp-1
is not essential for the development of memory CD8+ T cell but
is required for their functional response to subsequent viral chal-
lenge. Thus, Blimp-1 controls the differentiation of cytotoxic
effector cells from both naive and memory CD8+ T cells.
RESULTS
Blimp-1 Is Required for Protection against Influenza
Infection
Infection of mice with influenza virus induces robust proliferation
of antigen-specific CD8+ T cells and their differentiation into
effector cells that are essential for efficient elimination of the
virus (Belz et al., 2001). In order to assay Prdm1 expression
during an acute antiviral immune response, we took advantage
of Prdm1gfp knockin mice that allow monitoring of Prdm1
expression on a single-cell level by using GFP as a surrogate
marker (Kallies et al., 2004). Prdm1gfp/+ mice were infected
with influenza virus, and the CD8+ T cells in the spleen and lungs,
the primary site of infection, were analyzed at the peak of the
response. Two infection regimes were used. For primary infec-
tions, mice were challenged intranasally (i.n.) with the influenza
strain HKx31, whereas to study heterosubtypic recall responses,
mice were first primed with the serologically distinct PR8 strain
intraperitoneally (i.p.) and rechallenged with the HKx31 strain
i.n. 6–8weeks later (Belz et al., 2000).With either infectionmodel,
CD8+ T cells specific for the immunodominant viral epitopes
nucleoprotein (DbNP366-374, termed NP) and acid polymerase
(DbPA224-233, PA) (Belz et al., 2000, 2001) expressed a low but
uniform amount of Prdm1 as measured by GFP fluorescence
(Figure 1A and data not shown).
We next wished to determine whether Blimp-1 was important
for antiviral CD8+ T cell responses. Because mice homozygous
for the Prdm1gfp allele die in utero (Robertson et al., 2007), we re-
constituted irradiated recipient mice with fetal liver cells to
generate chimeric mice that lack functional Blimp-1 in their
immune system (termed Prdm1gfp/gfpmice) or Blimp-1-sufficient
control mice (termed wild-type). Chimeric mice were then sub-
jected to the influenza infection regimes outlined above. Primary
infection of wild-type mice resulted in transient weight loss
without overt signs of pathology, whereas infection of previously
primed mice resulted in a more rapid return to preinfection body
weight. In contrast, Prdm1gfp/gfp mice showed clinical signs of
respiratory distress and progressive weight loss after infection
regardless of the infection scheme applied (Figure 1B). Histolog-
ical examination of the lungs from infected animals revealed
severe pathology in Prdm1gfp/gfp mice characterized by tissue
destruction and infiltration of T, B, and myeloid cells (Figure 1C
and data not shown). The failure of Prdm1gfp/gfp mice to be pro-
tected from the pathology caused by the infection was not due to
a diminished antigen-specific CD8+ T cell response, as indicated
by the fact that the frequency of virus-specific (NP+) CD8+ T cells
in the spleens of these mice was increased compared with wild-
type mice (Figure 1D).
Both cellular and humoral factors may contribute to the failure
of Prdm1gfp/gfp mice to efficiently clear an influenza infection284 Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc.(Doherty et al., 2006). We therefore wished to discriminate
between the contributions of Blimp-1 deficiency in B and T cells
to the phenotype observed in influenza-infected Prdm1gfp/gfp
mice. To do so, we made use of a new conditional Blimp-1
mutant in which exon 6 of the gene encoding Blimp-1 is flanked
by loxP sites (Prdm1fl) allowing the conditional deletion of most
of the coding sequence of Prdm1. Prdm1fl/flLckCre+mice, which
lack detectable expression of Blimp-1 in their T cells (Figure S1
available online) and control mice (Prdm1+/flLckCre+ or Prdm1fl/fl
LckCre), were infected with HKx31 influenza virus and
pathology was examined. Prdm1fl/flLckCre+ recovered from
infection, although with some delay (Figure S1). Flow cytometric
analysis and histological examination revealed increased cellular
infiltration as well as altered distribution of lymphocytes in the
lungs compared to control mice (Figure S1), highlighting a signif-
icant role for Blimp-1 in T cells during an immune response
against influenza virus.
Blimp-1 Is Required for Trafficking of CD8+ T Cells
Previous studies have shown that Blimp-1 is essential to main-
tain CD4+ T cell homeostasis and has functions in regulatory
T cells (Kallies et al., 2006; Martins et al., 2006). In order to deter-
mine the CD8+ T cell-intrinsic role of Blimp-1, we generated
mixed bone marrow chimeric mice by reconstituting lethally
irradiated recipient mice (Ly5.1+) with a 1:1 mixture of congenic
Ly5.2+Prdm1gfp/gfp (Blimp-1-deficient) and Ly5.1+Prdm1+/+
(wild-type) bone marrow. In this approach, wild-type T cells
(and B cells) were present throughout the immune response
and any potential dominant phenotype of Prdm1gfp/gfp cells
would act on both wild-type and Blimp-1-deficient CD8+
T cells. As expected, the provision of wild-type cells overcame
the lethality and overt pulmonary pathology associated with
influenza infection of Prdm1gfp/gfp mice (data not shown). This
experimental approach thus allowed us to perform side-by-
side comparison of influenza-specific CD8+ T cell responses in
the presence and absence of functional Blimp-1.
Naive or PR8-primed mixed bone marrow chimeric mice were
infected with HKx31 and the frequency of influenza-specific
CD8+ T cells of either genotype was determined in the spleen,
lungs, and the lung-draining mediastinal lymph nodes (mLN) at
the peak of the response (day 10 for HKx31; day 8 for PR8,
HKx31). After a primary infection, the frequency of NP+CD8+
T cells in the spleen and mLN was similar between the geno-
types, whereas a reduction of NP+CD8+ T cells was found in
the Prdm1gfp/gfp compartment of the lung (Figure 2A, left). In
line with this, calculation of the relative contribution of the each
genotype to NP+CD8+ T cells in each tissue revealed that
Prdm1gfp/gfp cells were reduced in the lungs when compared
to the competing wild-type cells of the same specificity (Fig-
ure 2B). Infection of PR8-primed chimeras resulted in amarkedly
elevated proportion of NP+ cells in the Prdm1gfp/gfp CD8+ T cell
compartment of the spleen but not of the lung (Figure 2A, right).
When the contribution of Prdm1gfp/gfp NP+CD8+ T cells was
examined in each tissue, it was apparent that the relative
frequency of Prdm1gfp/gfp cells was markedly increased in both
the spleen and the mLN but again was strongly reduced in the
lungs compared to competing wild-type cells (Figure 2C). These
data indicate that Prdm1gfp/gfp CD8+ T cells can respond to influ-
enza challenge; however, they are underrepresented in the lung
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Blimp-1 Is Required for Effector CD8+ T CellsFigure 1. Blimp-1 Is Expressed in Influenza-Specific CD8+ T Cells and Mice Lacking Blimp-1 in Their Hematopoietic System Fail to Control
Influenza Infection
Prdm1+/gfp or wild-type (+/+) mice (A) or mice reconstituted with +/+ or Prdm1gfp/gfp (gfp/gfp) fetal liver cells (B–D) were infected with influenza virus.
(A) Analysis of Blimp-1-GFP and virus specificity (DbNP366
+) in gated CD8+ T cells of +/gfp mice after influenza infection. Naive (left) or PR8-primed (right) mice
were infected as indicated and analyzed at the peak of the response (day 10 for naivemice and day 8 for PR8-primedmice). Data are representative of aminimum
of 12 mice per genotype.
(B) Progressive weight loss in mice lacking Blimp-1 function in the hematopoietic compartment after influenza infection of naive (left) or PR8-primed (right) mice.
Data are shown as percent initial bodyweight (mean ± SD). 6 out of 8 naive mice infected with HKx31 had to be euthanized before the completion of the exper-
iment (symbolized with asterisk).
(C) Histological examination of two representative lung samples from influenza-infectedmice (PR8 primed) of the indicated genotypes. gfp/gfp lungs show severe
tissue damage and lymphocytic infiltration.
(D) Enumeration of the proportion of total CD8+ T cells that are DbNP366
+ in the spleens of PR8-primed and influenza-infected +/+ and gfp/gfp mice.
Data in (C) and (D) are representative of a minimum of 5 mice per genotype.and accumulate in spleen and draining lymph node, suggesting
that Blimp-1 regulates trafficking of virus-specific CD8+ T cells to
the site of infection. A similar paucity of Prdm1gfp/gfp cells was
also observed for the subdominant PA epitope, demonstrating
that the impaired trafficking to the lung was not restricted to
the dominant NP specificity (Figure S2). Examination of infected
chimeric mice at earlier (day 5) and later (day 15) time points re-
vealed a similarly altered distribution of virus-specific Blimp-1-
deficient CD8+ T cells, suggesting that the kinetics of the
responsewas similar in the absence of Blimp-1 (data not shown).
Analysis of genes involved in trafficking of lymphocytes during
an infection revealed that the expression of the gene encoding
CCR5, a chemokine receptor crucial for the recruitment of influ-enza-specific T cells to the lung (Kohlmeier et al., 2008), was not
as strongly activated in the absence of Blimp-1, as compared to
wild-type CD8+ T cells (Figure 2D). In contrast, Ccr7, encoding
the chemokine receptor CCR7, was expressed at a markedly
higher level in Blimp-1-deficient NP+CD8+ T cells compared to
wild-type effector cells (Figure 2D). CCR7 is essential for the
localization of naive and memory T cells in lymphoid organs,
whereas its downregulation is required for effector cells to
migrate to tissues (Forster et al., 2008). To test the functional
relevance of the increased Ccr7 expression in Blimp-1-deficient
NP+CD8+ T cells, we measured migration in response to re-
combinant CCL19, the ligand of CCR7. Prdm1gfp/gfp NP+CD8+
T cells displayed a significantly stronger migratory response inImmunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 285
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Blimp-1 Is Required for Effector CD8+ T CellsFigure 2. Blimp-1-Deficient CD8+ T Cells Show Diminished Migration to the Lung in Response to Influenza Infection
(A) Naive (left) or PR8-primed (right) bone marrow chimeric mice reconstituted with a mix of Prdm1gfp/gfp (gfp/gfp, Ly5.2+) and wild-type (+/+, Ly5.1+) cells were
analyzed at day 8–10 after HKx31 infection. Single-cell suspensions from the spleen and lungwere analyzed for the expression of CD8, Ly5.2, and influenza spec-
ificity (DbNP366). Representative plots of gated CD8
+ T cells from spleen (top) and lung (bottom) are shown.
(B and C) Bone marrow chimeric mice as in (A) were infected as indicated and the relative contribution of Blimp-1-deficient CD8+ T cells to the DbNP366-specific
response in the different tissues was calculated at the indicated time points after infection (as log2 of the ratio of gfp/gfp CD8
+DbNP366
+ / +/+ CD8+DbNP366
+
T cells). To allow for variation in the reconstitution frequency, data were normalized for the proportion of the total CD8+ T cell compartment in the spleen from
each genotype. Each symbol represents data from an individual recipient mouse. p values above the graphs compare the indicated groups. p values below
the graphs compare the test group to 0 (n.s., not significant p > 0.05).
(D) +/+ and gfp/gfpCD8+ DbNP366
+ T cells were sorted from the spleens of PR8-primedmice that were infected i.n. with HKx31 8 days previously and analyzed by
quantitative RT-PCR for the indicated transcripts. Data are shown as the expression relative to that found in naive +/+ CD8+ T cells (arbitrarily set to 1) and repre-
sent the pooled results of 3–4 biologically independent samples (mean ± SEM).comparison to their wild-type counterparts (Figure S2). The
significance of our findings was further assessed by transferring
wild-type and Blimp-1-deficient NP+CD8+ T cells, isolated at the
peak of the T cell response, into naive recipients. Analysis of
recipient mice after 24 hr revealed that the Prdm1gfp/gfp
NP+CD8+ T cells migrated with higher efficiency to the lymph no-286 Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc.des but were impaired in their trafficking to the lung whereas
wild-type cells showed the inverse migration pattern (Figure S2).
Taken together, these data suggest that the repression of Ccr7
expression provides a mechanism by which Blimp-1 controls
the efficient exit of antigen-specific CD8+ T cells from lymph
node.
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of CD8+ T Cells
In order to examine whether Blimp-1 deficiency impacts on
effector functions, we measured cytokine production from
NP+CD8+ T cells by intracellular staining and flow cytometric
analysis. After primary HKx31 infection, no significant changes
in the cytokine production of Blimp-1-sufficient and -deficient
CD8+ T cells was observed (Figure 3A). In line with the elevated
proportion of antigen-specific CD8+ T cells in the spleen after
PR8 priming and subsequent HKx31 infection, the proportion
of Blimp-1-deficient cells producing interferon g (IFN-g) was
strongly increased (Figure 3B; Figure S4). A small but significant
(p < 0.02) increase in IFN-g was also seen when the number of
IFN-g+ CD8+ T cells after NP-peptide stimulation was related
to the number of NP+CD8+ T cells in the spleen but not in the
lung (Figures S3 and S4). Blimp-1-deficient antigen-specific
CD8+ T cells showed an even more pronounced increase in
production of tumor necrosis factor a (TNF-a), whereas IL-2
production was restricted to the Blimp-1-deficient compart-
ment, highlighting a role for Blimp-1 in regulating the balance
of cytokines secreted in response to virus (Figure 3B; Figures
S3 and S4).
The failure of Blimp-1-deficient CD8+ T cells to efficiently
control influenza infection suggested that elements of the cyto-
lytic machinery of effector T cells might be disrupted. Indeed,
Blimp-1-deficient CD8+ T cells were markedly impaired in their
antigen-induced cytolytic activity (Figure 3C; Figure S3). In line
with this, Granzyme B (GzmB), a major mediator of CD8+ T cell
cytotoxicity, was virtually absent from total and NP-specific
Prdm1gfp/gfp CD8+ T cells in primary and recall responses, re-
spectively (Figure 3D). This was further supported by the analysis
ofGzmb transcripts, which were nearly undetectable in Blimp-1-
deficient virus-specific CD8+ T cells (Figure 3E). The expression
of genes encoding other mediators of cytotoxic killing, such as
Granzyme K (Gzmk) and Perforin (Prf1), were only partially
impaired and were probably responsible for the residual killing
activity of the Blimp-1-deficient CD8+ T cells (Figure 3E).
Blimp-1-Deficient T Cells Fail to Differentiate
into Short-Lived Effector T Cells
During infection, KLRG1hiIL-7RloCD8+ T cells have been identi-
fied as effector cells that lack memory potential, whereas
KLRG1loIL-7Rhi cells were memory precursors that gave rise to
long-lived memory T cells (Joshi et al., 2007). Analysis of influ-
enza-infected mice revealed that approximately 30% of
NP+CD8+ T cells in the spleen and lungs at the peak of the
immune response expressed high amounts of KLRG1, had
downregulated IL-7R, and uniformly expressed Prdm1 (Fig-
ure 4A; Figure S5). Importantly, analysis of infected mixed
bone marrow chimeric mice at the same time point showed
that Blimp-1-deficient NP+CD8+ T cells in spleen and lung failed
to upregulate KLRG1 and maintained high expression of IL-7R
(Figures 4B and 4C; Figure S5). The absence of KLRG1+IL-7Rlo
effector cells was a uniform feature of Blimp-1-deficient CD8+
T cells as shown by the fact that it occurred in both primary
and recall responses. This observation was further supported
by the findings of elevated Il7r and strongly reduced Klrg1 tran-
scripts in the absence of Blimp-1 (Figure 4D). Virus-specific
Blimp-1-deficient CD8+ T cells also showed elevated expressionof CD62L and were homogenously positive for CD27 (Figure 4E),
a phenotype consistent with impaired effector differentiation
(Hikono et al., 2007). These results taken together with the
elevated production of IL-2, the virtual absence ofGzmb expres-
sion, and impaired cytolytic activity demonstrate that Blimp-1-
deficient antigen-specific CD8+ T cells at the peak of the immune
response display a memory precursor rather than an effector
phenotype.
Blimp-1 Regulates the Transcriptional Program
in Antigen-Specific T Cells
A small number of transcription factors, including T-bet and
Eomes, are known to be important in the regulation of effector
and memory CD8+ T cell differentiation (Kallies, 2008). Quantita-
tive RT-PCR analysis of virus-specific CD8+ T cells revealed that
Tbx21 (encoding T-bet) was induced in Blimp-1-deficient cells
but at a lower amount than in wild-type cells, whereas Eomes
expression was markedly higher in the absence of Blimp-1 (Fig-
ure 5).Bcl6, another transcription factor that has been implicated
in memory T cell function (Ichii et al., 2002), was also expressed
at 2-fold higher amounts in Blimp-1-deficient cells (Figure 5),
a finding consistent with a previous report that Blimp-1 directly
represses Bcl6 in CD4+ T cells (Cimmino et al., 2008). These
data suggest that Blimp-1 is required to establish the transcrip-
tional profile associated with effector cells and in its absence
a memory-type transcriptional program predominates.
Blimp-1 Regulates Quantity and Quality of Memory
T Cells
The preferential differentiation of Blimp-1-deficient virus-specific
CD8+ T cells into cells with a memory-precursor phenotype sug-
gested that these cells would give rise to an elevated frequency
of memory T cells. Indeed, examination of bonemarrow chimeric
mice 10–19 weeks after the resolution of the infection showed
an increased proportion of NP+CD8+ memory T cells in the
Prdm1gfp/gfp compartment (Figure 6A). Phenotypic analysis of
these cells revealed that although most wild-type cells were
IL-7RhiCD62Llo, i.e., displayed an effector memory phenotype,
a much larger proportion of Blimp-1-deficient CD8+ memory
T cells were IL-7RhiCD62Lhi, indicative of central memory
T cells (Figure 6B). The increased proportion of influenza-specific
Prdm1gfp/gfp central memory T cells occurred after HKx31 infec-
tion of both naive and PR8-primed mice (Figures 6A and 6B).
Thus, Blimp-1 regulates the quantity and quality of memory
T cells generated in response to influenza infection. Consistent
with this function, Blimp-1 expression was retained in
NP+CD8+ memory T cells, albeit at a slightly lower amount
than in effector cells (Figure 6C).
Blimp-1-Deficient Memory T Cells Are Functionally
Impaired
A cardinal feature of memory T cells is their ability to respond
rapidly to antigenic stimulation with proliferation and acquisition
of effector function (Williams and Bevan, 2007; Kalia et al., 2006).
Although the pronounced response of PR8-primed mice upon
rechallenge with HKx31 suggested that Blimp-1-deficient CD8+
T cells were able to be recalled, the altered effector cell differen-
tiation and increased central memory cell formation in the
absence of Blimp-1 after primary infection made quantitation ofImmunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 287
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Blimp-1 Is Required for Effector CD8+ T CellsFigure 3. Blimp-1-Deficient CD8+ T Cells Fail to Differentiate into Cytotoxic Effector Cells
(A) CD8+ T cells were enriched from the spleen of chimeric mice at day 10 after HKx31 infection and restimulated for 5 hr in vitro with influenza peptide
(DbNP366-374) before being assessed for cell-surface expression of Ly5.2, CD8, and intracellular cytokine production as indicated. Plots have been gated on
the basis of CD8+Ly5.2+ (gfp/gfp) or CD8+Ly5.2 (+/+) expression.
(B) PR8-primedmice were infected with HKx31 and analyzed for cytokine secretion at day 8 as described in (A). No specific cytokine production was observed in
the absence of DbNP366-374 peptide or influenza infection (Figure S4).
(C) Impaired cytotoxicity of Blimp-1-deficient CD8+ T cells. +/+ (Ly5.2) and gfp/gfp (Ly5.2+) CD8+ T cells were sorted from the spleens of PR8-primed chimeric
mice, at day 8 after HKx31 infection. The proportion of DbNP366
+ cells was determined in each population and the cells were subjected to a 51Cr release assaywith
DbNP366-374-peptide-pulsed EL4 cells at the indicated effector to target ratios. Background lysis of nonpeptide-pulsed EL4 cells (<15%) was subtracted from the
specific signal. Data are representative of 4 independent experiments.
(D) Intracellular granzyme B (GzmB) staining of CD8+ T cells from chimeric mice infected with influenza virus. Top panels show cells from naive mice infected with
HKx31, whereas the lower panel shows cells from mice that have been primed with PR8 before infection with HKx31.
(E) Blimp-1-deficient cells show diminished expression of cytotoxic mediators. +/+ and gfp/gfp CD8+DbNP366
+ T cells were sorted from PR8-primed mice in-
fected with HKx31 and analyzed by quantitative RT-PCR for the expression of cytotoxic mediators as described for Figure 2D. Data are the mean ± SEM.288 Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc.
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rately measure the recall response of memory T cells generated
either in the presence or absence of Blimp-1, we sorted wild-
type and Prdm1gfp/gfp NP+CD8+ memory T cells from HKx31-in-
fected chimeric mice and transferred them separately into naive
congenic hosts. This approach allows the memory capacity of
defined numbers of influenza-specific CD8+ T cells to be as-
sayed in the absence of nonintrinsic variables such as memory
CD4+ T cells and memory B cells. After infection of recipient
mice with influenza virus, donor wild-type T cells expanded in
number and dominated the NP-specific CD8+ T cell response.
Prdm1gfp/gfp memory CD8+ T cells, however, although showing
some capacity to increase in number, were outcompeted by the
endogenous primary response (Figure 6D and data not shown).
Similar results were obtained when CD8+ T cells (containing
equivalent numbers of NP+ cells) were sorted at day 10 after
HKx31 infection and transferred into naive hosts where they
were allowed to differentiate into memory cells before rechal-
lenge (Figures 6E and 6F). Given the central memory phenotype
of the Blimp-1-deficient CD8+ T cells, this finding was surprising
and we wished therefore to more rigorously test the function of
Prdm1gfp/gfp memory T cells in a competitive situation. Equal
numbers of wild-type and Prdm1gfp/gfp CD8+ T cells from primed
and HKx31-infected bone marrow chimeric mice were trans-
ferred into naive Ly5.1 3 Ly5.2 (F1) recipient mice, which were
subsequently infected with influenza virus. This approach
excludes the possibility that the impaired response of Blimp-1-
deficient memory T cells was specific only to the dominant
NP epitope or biased by a differential persistence of Ly5.1- or
Ly5.2-positive cells in congenic hosts. The memory recall
response in this competitive situation was again dominated by
the transferred wild-type CD8+ T cells, which outcompeted
both the endogenous and the Prdm1gfp/gfp response (Figure 6G).
To rule out the possibility that Blimp-1-deficient CD8+ T cells fail
to be maintained in recipient mice, CD8+ T cells were isolated
from influenza-infected chimeric mice, labeled with Carboxy-
fluorescein succinimidyl ester (CFSE), and transferred into naive
F1 recipients. Analysis of the transferred cells 4 weeks later
demonstrated that wild-type and Prdm1gfp/gfp cells were main-
tained at a similar amount whereas CFSE dilution demonstrated
a comparable low turnover typical for memory T cells (Figure S5).
Thus, Blimp-1 is dispensable for the maintenance of memory
CD8+ T cells but required for their efficient recall in response to
viral rechallenge.
DISCUSSION
Despite the established role for Blimp-1 in the maintenance of
T cell homeostasis and in the prevention of T cell-mediated
pathology (Kallies et al., 2006; Martins et al., 2006), the function
of Blimp-1 during normal T cell responses has not been deter-
mined. Here we show that Blimp-1 is essential for the migration
and differentiation of effector CD8+ T cells and an efficient recall
of memory CD8+ T cells.
In the current study, we demonstrate that Blimp-1 is essential
for appropriate homing of influenza-specific CD8+ T cells to the
lungs. This impairedmigration occurred despite the normal initial
expansion of antigen-specific CD8+ T cells during a primary
infection. The perturbed trafficking of antigen-specific CD8+T cells in the absence of Blimp-1 was even more pronounced in
recall responses, which led not only to diminished migration to
the lung but also to a marked accumulation of Blimp-1-deficient
antigen-specific CD8+ T cells in the spleen and draining lymph
nodes. Trafficking of effector cells to the infected tissue is crucial
for an efficient cytotoxic immune response and is closely linked
to changes in the expression of chemokine receptors during
effector T cell differentiation. It has been demonstrated that
although expression of CCR7 is essential for the localization of
naive andmemory T cells in lymphoid organs, its downregulation
on effector T cells is required for migration to tissues (Forster
et al., 2008). CCR5, in contrast, is required for the recruitment
of influenza-specific T cells to the lung (Kohlmeier et al., 2008).
Blimp-1-deficient CD8+ T cells failed to downregulate Ccr7
appropriately and showmildly impairedCcr5 expression. Conse-
quently, during an influenza infection, Blimp-1-deficient CD8+
T cells accumulate in the spleen and in the lung-draining lymph
nodes but fail to be efficiently recruited to the lung.
Our knowledge of the transcriptional networks that control
effector and memory CD8+ T cell differentiation remains limited
(Kallies, 2008). The T box transcription factors T-bet and Eomes
are thought to be crucial in the process. T-bet is expressed at
high amounts in effector CD8+ T cells, but at lower amounts in
memory CD8+ T cells (Intlekofer et al., 2007; Joshi et al., 2007),
whereas Eomes is expressed predominantly in memory cells
(Pearce et al., 2003; Takemoto et al., 2006). The coexpression
of Eomes and T-bet in memory T cells is important as these
factors act redundantly to induce the transcription of Il2rb, a
component of the IL-2R and IL-15R complex crucial for memory
T cell homeostasis (Intlekofer et al., 2005). Eomes and T-bet are
also redundantly required for IFN-g production and cytotoxicity
of CD8+ T cells during lymphocytic choriomeningitis virus
(LCMV) infection (Intlekofer et al., 2008). In the current study
we have found that Tbx21 (encoding T-bet) was induced in
Blimp-1-deficient cells, but at a lower amount than in wild-type
cells. In contrast, Eomes expression was markedly higher in
the absence of Blimp-1. This altered ratio of T-bet and Eomes
is of significance because the functions of both transcription
factors are highly dosage sensitive (Intlekofer et al., 2005; Joshi
et al., 2007). For example, relatively subtle increases in T-bet
expression (2- to 4-fold), driven by IL-12, favor effector differen-
tiation at the expense of memory CD8+ T cells, whereas the
inactivation of one Tbx21 allele results in enhanced memory
formation (Joshi et al., 2007). Blimp-1 is unlikely to function
immediately downstream of T-bet and Eomes in CD8+ T cells
because, in contrast to singular deletion of either of those factors,
Blimp-1 deficiency alone results in a failure to induce GzmB,
a major component of the cytotoxic machinery and strongly
impaired killing.
The generation of a diverse pool of effector andmemory T cells
is instrumental to the success of an immune response. The
developmental origin of this diversity is, however, controversial.
Although many studies conclude that memory T cells arise
during the contraction phase of an immune response and sug-
gest that they develop from effector cells (Wherry et al., 2003;
Bannard et al., 2009), other data indicate that memory cells or
their precursors can differentiate in parallel to effector cells
directly from naive T cells (Joshi and Kaech, 2008; Teixeiro
et al., 2009). Such an early dichotomy in T cell differentiation
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stimulation, the cytokine milieu (Joshi and Kaech, 2008; Maso-
pust et al., 2004; Williams and Bevan, 2007) or through mecha-
nisms such as asymmetric cell division (Chang et al., 2007).
Studies with LCMV infection have provided support for such
a model of effector and memory T cell differentiation by demon-
strating that both effector- and memory-precursor CD8+ T cells
can already be identified at the peak of an immune response
(Joshi et al., 2007). Our data suggest a similar early dichotomy
of effector and memory T cell fates during influenza infection
and demonstrate that Blimp-1 is crucial for this process. Further-
more, we show that Blimp-1 restricts the memory potential of
CD8+ T cells as shown by the fact that Blimp-1 deficiency led
to increased frequencies of bothmemory precursor andmemory
cells, which is compatible with a model in which Blimp-1 drives
CD8+ T cells into the effector differentiation pathway.
Blimp-1 also regulates the type of the memory T cell
produced, as indicated by the fact that in its absence both
primary and secondary infections resulted in a bias toward
a central memory phenotype. Although these cells could be re-
called upon reinfection, we found that Blimp-1-deficient memory
T cells under conditions that allow accurate quantitation failed to
efficiently compete with wild-type memory cells. Thus, Blimp-1
is dispensable for the generation of memory CD8+ T cells but
is required for the efficient recall, a finding that is consistent
with similar requirements for Blimp-1 in the differentiation of
effector cells from both naive and memory precursors.
Figure 5. Blimp-1 Regulates the Differentiation Program of CD8+
T Cells during an Antiviral Response
Wild-type (+/+) and Blimp-1-deficient (gfp/gfp) CD8+DbNP366
+ T cells were
sorted from PR8-primed mice that were infected i.n. with HKx31 8 days previ-
ously. The relative expression of the indicated transcripts was measured by
quantitative RT-PCR as described for Figure 2D. Data are the mean ± SEM.Two models can be envisaged to explain this differential
requirement of effector and memory CD8+ T cells for Blimp-1.
First, distinct concentrations of Blimp-1 may be of functional
relevance and drive memory and effector fates, respectively.
This is consistent with our previous work, which demonstrated
that the levels of Prdm1 expression define the stages of plasma
cell differentiation (Kallies et al., 2004), and the finding that
Prdm1 expression was 5-fold higher in LCMV-specific effector
CD8+ T cells compared to memory cells (Intlekofer et al.,
2007). Thus, effector CD8+ T cells may show a stronger Blimp-1
dependency resulting from increased expression levels. In
the current study, however, we have observed only slightly
higher GFP fluorescence in influenza-specific effector cells
compared to memory cells with the same antigen specificity.
An alternative possibility is that Blimp-1 is not only required in
effector T cells but also acts early in memory precursors to
establish a transcriptional context that is permissive for effector
cell differentiation, potentially through controlling the relative
balance of factors that promote either effector (T-bet) or memory
(Eomes, Bcl6) fates. In this model, the terminal differentiation of
effector CD8+ T cells requires both Blimp-1 and a parallel, inflam-
matory, pathway that supports high T-bet expression (Joshi
et al., 2007). This latter possibility is in line with the finding that
Prdm1 expression in activated T cells is regulated by IL-2
(Martins et al., 2008; Gong and Malek, 2007; Santer-Nanan
et al., 2006) and that memory T cells generated in the absence
of IL-2 signaling are, similar to Blimp-1-deficient memory cells,
functionally impaired in their ability to differentiate into effector
cells (Williams et al., 2006). Thus our data directly implicate
Blimp-1 in the ‘‘programming’’ of memory T cells.
Terminal differentiation is a generally irreversible process that
leads to the acquisition of effector functions and often exit from
the cell cycle (Kallies and Nutt, 2007). Although the terminal
differentiation program of plasma cells is well characterized,
the late stages of T cell differentiation into the various subsets
of memory and effector T cells are less understood. In conjunc-
tion with the wealth of data that support a key role for Blimp-1 in
plasma cell differentiation, our results suggest a common
requirement for Blimp-1 in controlling the later stages of B cells
and CD8+ T cell differentiation, as shown by the fact that in
both lineages, the initiation of the developmental program and
the acquisition of some effector functions are Blimp-1 indepen-
dent, whereas full terminal differentiation requires Blimp-1 (Kal-
lies et al., 2007; Nutt et al., 2007). This, combined with the
surprising similarities in the transcriptional profiles of both
memory T and B cells that have been described recently (Haining
et al., 2008), demonstrates conservation of the regulation of
terminal differentiation in T and B cells.Figure 4. Expression of Blimp-1 Is Required for the Differentiation of Effector CD8+ T Cells
(A) Naive wild-type (+/+) and Prdm1+/gfpmice were infected with HKx31 and virus-specific (DbNP366
+) responses measured 8 days later. Single-cell suspensions
from the spleen and lung were analyzed for the expression of CD8, KLRG1, Blimp-1-GFP, and DbNP366. Gated CD8
+ T cells are shown.
(B and C) Naive (B) or PR8-primed (C) bone marrow chimeric mice were infected with HKx31 and virus-specific (DbNP366
+) responses measured 8 days later.
Splenocytes were analyzed for CD8, Ly5.2, KLRG1, and IL-7R. Plots have been gated for CD8+DbNP366
+ T cells. Plots in (C) were gated for CD8+DbNP366
+
T cells on the basis of Ly5.2+ (gfp/gfp) and Ly5.2 (+/+) expression. Mean fluorescent index (MFI) of IL-7R is shown for CD8+DbNP366
+ T cells. Data are repre-
sentative of at least 5 independent experiments with groups of at least 3 mice per genotype.
(D and E) PR8-primedmixed bonemarrow chimeric mice were infected with HKx31. 8 days later +/+ and gfp/gfpCD8+DbNP366
+ T cells were sorted and either (D)
analyzed by quantitative RT-PCR for the indicated transcripts as described for Figure 2D or (E) analyzed for the surfacemarkers as indicated. Data are themean ±
SEM.Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 291
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Efficient Memory Recall
(A) Naive (left) or PR8-primed (right) mixed chimeric mice were infected i.n. with HKx31 strain and percentage of spleen CD8+ memory T cells that were DbNP366
+
was enumerated after the indicated number of days. Wild-type (+/+) cells were Ly5.2, Blimp-1-deficient (gfp/gfp) cells were Ly5.2+. Data are the mean ± SEM.292 Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc.
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Mice
Prdm1gfp/+ mice were maintained on a pure C57BL/6 (Ly5.2) background as
has been described previously (Kallies et al., 2004). The generation of the
Blimp-1 floxed allele (Prdm1fl) is described in the Supplemental Experimental
Procedures. Prdm1gfp/gfp mice and wild-type controls were generated from
lethally irradiated B6.SJL-PtprcaPep3b/BoyJ (Ly5.1) mice reconstituted with
fetal liver cells from E14.5 Prdm1gfp/gfp embryos or Prdm1+/+ littermate
controls. Only mice with <10% host-derived CD8+ T cells after influenza infec-
tionwere considered to be predominantly Blimp-1 deficient and included in the
study. Mixed bone marrow chimeras were generated from lethally irradiated
(2 3 5.5 Gy) Ly5.1 mice reconstituted with a 1:1 mixture of bone marrow cells
of Prdm1gfp/gfp and Ly5.1 mice. Chimeric mice were used for infections 6–8
weeks after reconstitution and the relative contribution of Prdm1gfp/gfp
(Ly5.2) or Ly5.1 cells was determined by flow cytometric analysis of spleen
at the completion of an experiment. The presence of residual host cells in
C57BL/6 recipients reconstituted with Prdm1gfp/gfp bone marrow suppresses
the immune pathology observed in Rag1/ mice reconstituted with Blimp-
1-deficient fetal liver cells (Kallies et al., 2006). Ly5.2, Ly5.1, or Ly5.2 3
Ly5.1 (F1) mice were used as recipients for adoptive transfer of memory
T cells. Mice were maintained and used in accordance with the guidelines of
the Walter and Eliza Hall Institute Animal Ethics Committee.
Viral Infections
Mice were inoculated i.n. with 104.5 p.f.u. of the HKx31 (H3N2) influenza virus
(Belz et al., 2000; Flynn et al., 1998). To measure recall responses, mice were
first inoculated i.p. with 107 plaque-forming units (p.f.u.) of the heterologous
A/PR/8/34 (H1N1, PR8, Mt. Sinai strain) influenza virus and then challenged
i.n. with 104.5 p.f.u. of HKx31 6–8 weeks later (Belz et al., 2000; Flynn et al.,
1998). Virus stocks were grown in the allantoic cavity of 10 days embryonated
hen’s eggs and stored in aliquots at 80C.
Measuring Antiviral CD8+ T Cell Responses
Antiviral T cell responses were enumerated by staining with phycoerythrin
(PE)-labeled MHC class I tetrameric complexes specific for the two H-2b-
restricted immunodominant epitopes of influenza virus, namely the nucleopro-
tein (NP; DbNP366-374) and acid polymerase (PA; D
bPA224-233) (Belz et al., 2000;
Flynn et al., 1998). To measure antigen-specific cytokine expression, spleno-
cytes enriched for CD8+ T cells were stimulated in the presence of 1 mM
DbNP366-374 (Townsend et al., 1985) or D
bPA224-233 (Belz et al., 2000) peptide
and 1 mg/ml Brefeldin A (Epicenter Biotechnologies) for 5 hr. Cells were then
stained for relevant surface molecules, fixed, and permeabilized with the
Cytofix/Cytoperm reagent (BD Biosciences) and costained for intracellular
cytokine. Intracellular Granzyme B content of cells was measured after stimu-
lation of the cells with 50 ng/ml phorbol myristate acetate (PMA) and 500 ng/ml
ionomycin for 5 hr (with 1 mg/ml Brefeldin A for the last 2 hr) and subsequentsurface marker stain (CD8, Ly5.2, DbNP366-tetramer). In some cases, CD8
+
T cells were cultured in the presence of 1 mM DbNP366-374 peptide and
T cell-depleted irradiated splenocytes. After 3 days, cultures were restimu-
lated with PMA, ionomycin, and Brefeldin A and analyzed for cytokine produc-
tion as described above. The relative contribution of the respective genotypes
to the DbNP366
+CD8+ T cell responses in the lung and mLN was determined as
the ratio of Prdm1gfp/gfp DbNP366
+CD8+ / +/+ DbNP366
+CD8+ T cells corrected
by the total contribution of the Prdm1gfp/gfp CD8+ T cells in the spleen (CD8+
Prdm1gfp/gfp/CD8+ wild-type). A paired two-tailed t test was used to determine
statistical significance.
To measure the turnover of memory cells, CD8+ T cells were enriched from
the spleens of chimeric mice 2 months after primary HKx31 infection and
labeled with CFSE as described (Lyons and Parish, 1994).
Flow Cytometry and Cell Sorting
Cells from spleen and lymph node were depleted of non-CD8+ cells prior to
surface staining or in vitro stimulation as previously described (Belz et al.,
2007). Lung lymphocytes were purified from single-cell suspensions by centri-
fugation on Histopaque (1.077 g/ml, Sigma-Aldrich) for 20 min at 2000 rpm at
room temperature. Flow cytometry and cell sorting and the antibodies used in
these procedures are described in Supplemental Experimental Procedures.
Ex Vivo Cytotoxicity Assay
Cytotoxicity of CD8 T cells was determined with a 51Cr-release assay as
described in Supplemental Experimental Procedures.
Real-Time PCR Analysis
Preparation of RNA, cDNA synthesis, PCR primers, and calculation of relative
mRNA expression levels are described in Supplemental Experimental Proce-
dures.
Migration Assays
The in vitro transwell migration assay is described in Supplemental Experi-
mental Procedures.
Histology
Organs were harvested and fixed overnight in 10% neutral buffered formalin at
4C. After fixation, organs were progressively dehydrated in 70%, 95%, and
100% ethanol, embedded in paraffin, sectioned, and stained with hematoxylin
and eosin. Images were acquired with a Zeiss Axioplan-2 microscope.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
immunity/supplemental/S1074-7613(09)00321-5.(B) Increased proportion of central memory T cells (CD62L+) in the absence of Blimp-1. Representative plot showing gated CD8+DbNP366
+ T cells from the +/+ and
gfp/gfp compartments of naive (top) or PR8-primed (bottom) mixed chimeric mice that were infected as in (A) and analyzed after the indicated number of days.
Results are representative of three independent experiments with 3–5 mice per group.
(C) Analysis of Blimp-1-GFP and DbNP366 specificity at day 10 (d10) and day 60 (d60) after HKx31 infection of naivemice. Gated CD8
+DbNP366
+ T cells are shown.
MFI was calculated by subtracting the fluorescence of +/+ CD8+DbNP366
+ T cells from the equivalent population of Prdm1+/gfp cells.
(D) Determination of the recall response of virus-specific CD8+ memory T cells. +/+ or gfp/gfp CD8+DbNP366
+ memory T cells were sorted from the spleens of
chimeric mice 60 days after HKx31 infection and the indicated number of CD8+ T cells were transferred separately into naive congenic recipient mice. One
day later, the recipients were infected with HKx31 and donor CD8+ T cells were enumerated in the spleen on day 10. Data are the mean ± SD and are represen-
tative of 2 experiments each with 3 mice per group and genotype.
(E and F) +/+ (Ly5.1+) and gfp/gfp (Ly5.2+) CD8+ T cells were sorted from the spleens of chimeric mice 8 days after HKx31 infection. 53 104 CD8+ T cells of each
genotype, containing equivalent numbers of DbNP366
+ cells, were transferred into naive congenic recipient mice as indicated above the plots. After 4 weeks, the
secondary recipient mice were infected with HKx31 and spleen and lung analyzed 8 days later.
(E) Representative dot plots of gated CD8+ cells are shown.
(F) Numbers of responding donor-derived CD8+DbNP366
+ T cells. Data are the mean ± SD and are representative of 3 independent experiments with at least
3 mice per group.
(G) +/+ (Ly5.1+) and gfp/gfp (Ly5.2+) CD8+ T cells were sorted from the spleens of PR8-primed chimeric mice 8 days after HKx31 infection, and 5 3 105 CD8+
T cells of each genotype, containing equivalent numbers of DbNP366
+ cells were transferred into Ly5.13 Ly5.2 (F1) mice. Recipients were infected after 4 weeks
with HKx31 and analyzed 8 days later for the presence of Ly5.2+ (gfp/gfp), Ly5.1+ (+/+), and Ly5.1+Ly5.2+ host cells. Gated CD8+ T cells are shown. Numbers
indicate percentage of donor cells in each circular gate. The results are representative of 2 independent experiments, each with 6 mice.Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 293
Immunity
Blimp-1 Is Required for Effector CD8+ T CellsACKNOWLEDGMENTS
We are grateful to N. Bernard, M. Camilleri, K. Elder, F. Masson, D. Tarlinton,
and E. Cretney for technical assistance and discussions. This work was sup-
ported by grants from the National Health and Medical Research Council of
Australia (NHMRC), the Leukemia & Lymphoma Society (A.K.), the Wellcome
Trust Foundation, the Howard HughesMedical Institute, the Viertel Foundation
(G.T.B.), and the Pfizer Australia Research Fellowship (S.L.N.).
Received: January 27, 2009
Revised: May 8, 2009
Accepted: June 9, 2009
Published online: August 6, 2009
REFERENCES
Bannard, O., Kraman, M., and Fearon, D.T. (2009). Secondary replicative func-
tion of CD8+ T cells that had developed an effector phenotype. Science 323,
505–509.
Belz, G.T., Xie, W., Altman, J.D., and Doherty, P.C. (2000). A previously unrec-
ognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-
specific CD8(+) T-cell response is much less apparent following secondary
challenge. J. Virol. 74, 3486–3493.
Belz, G.T., Xie, W., and Doherty, P.C. (2001). Diversity of epitope and cytokine
profiles for primary and secondary influenza a virus-specific CD8+ T cell
responses. J. Immunol. 166, 4627–4633.
Belz, G.T., Bedoui, S., Kupresanin, F., Carbone, F.R., and Heath, W.R. (2007).
Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells
favors the stimulation of naive CD8+ T cells. Nat. Immunol. 8, 1060–1066.
Chang, J.T., Palanivel, V.R., Kinjyo, I., Schambach, F., Intlekofer, A.M., Bane-
rjee, A., Longworth, S.A., Vinup, K.E., Mrass, P., Oliaro, J., et al. (2007). Asym-
metric T lymphocyte division in the initiation of adaptive immune responses.
Science 315, 1687–1691.
Cimmino, L., Martins, G.A., Liao, J., Magnusdottir, E., Grunig, G., Perez, R.K.,
and Calame, K.L. (2008). Blimp-1 attenuates Th1 differentiation by repression
of ifng, tbx21, and bcl6 gene expression. J. Immunol. 181, 2338–2347.
Doherty, P.C., Turner, S.J., Webby, R.G., and Thomas, P.G. (2006). Influenza
and the challenge for immunology. Nat. Immunol. 7, 449–455.
Flynn, K.J., Belz, G.T., Altman, J.D., Ahmed, R., Woodland, D.L., and Doherty,
P.C. (1998). Virus-specific CD8+ T cells in primary and secondary influenza
pneumonia. Immunity 8, 683–691.
Forster, R., Davalos-Misslitz, A.C., and Rot, A. (2008). CCR7 and its ligands:
Balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362–371.
Gong, D., and Malek, T.R. (2007). Cytokine-dependent Blimp-1 expression in
activated T cells inhibits IL-2 production. J. Immunol. 178, 242–252.
Haining, W.N., Ebert, B.L., Subrmanian, A., Wherry, E.J., Eichbaum, Q., Evans,
J.W., Mak, R., Rivoli, S., Pretz, J., Angelosanto, J., et al. (2008). Identification of
an evolutionarily conserved transcriptional signature of CD8 memory differen-
tiation that is shared by T and B cells. J. Immunol. 181, 1859–1868.
Hikono, H., Kohlmeier, J.E., Takamura, S., Wittmer, S.T., Roberts, A.D., and
Woodland, D.L. (2007). Activation phenotype, rather than central- or
effector-memory phenotype, predicts the recall efficacy of memory CD8+
T cells. J. Exp. Med. 204, 1625–1636.
Horsley, V., O’Carroll, D., Tooze, R., Ohinata, Y., Saitou, M., Obukhanych, T.,
Nussenzweig, M., Tarakhovsky, A., and Fuchs, E. (2006). Blimp-1 defines
a progenitor population that governs cellular input to the sebaceous gland.
Cell 126, 597–609.
Ichii, H., Sakamoto, A., Hatano, M., Okada, S., Toyama, H., Taki, S., Arima, M.,
Kuroda, Y., and Tokuhisa, T. (2002). Role for Bcl-6 in the generation and main-
tenance of memory CD8+ T cells. Nat. Immunol. 3, 558–563.
Intlekofer, A.M., Takemoto, N., Wherry, E.J., Longworth, S.A., Northrup, J.T.,
Palanivel, V.R., Mullen, A.C., Gasink, C.R., Kaech, S.M., Miller, J.D., et al.
(2005). Effector and memory CD8+ T cell fate coupled by T-bet and eomeso-
dermin. Nat. Immunol. 6, 1236–1244.294 Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc.Intlekofer, A.M., Takemoto, N., Kao, C., Banerjee, A., Schambach, F., North-
rop, J.K., Shen, H., Wherry, E.J., and Reiner, S.L. (2007). Requirement for
T-bet in the aberrant differentiation of unhelped memory CD8+ T cells.
J. Exp. Med. 204, 2015–2021.
Intlekofer, A.M., Banerjee, A., Takemoto, N., Gordon, S.M., Dejong, C.S., Shin,
H., Hunter, C.A., Wherry, E.J., Lindsten, T., and Reiner, S.L. (2008). Anomalous
type 17 response to viral infection by CD8+ T cells lacking T-bet and eomeso-
dermin. Science 321, 408–411.
Joshi, N.S., Cui,W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L.,
and Kaech, S.M. (2007). Inflammation directs memory precursor and short-
lived effector CD8(+) T cell fates via the graded expression of T-bet transcrip-
tion factor. Immunity 27, 281–295.
Joshi, N.S., and Kaech, S.M. (2008). Effector CD8 T cell development: A
balancing act between memory cell potential and terminal differentiation.
J. Immunol. 180, 1309–1315.
Kalia, V., Sarkar, S., Gourley, T.S., Rouse, B.T., and Ahmed, R. (2006). Differ-
entiation of memory B and T cells. Curr. Opin. Immunol. 18, 255–264.
Kallies, A. (2008). Distinct regulation of effector and memory T-cell differentia-
tion. Immunol. Cell Biol. 86, 325–332.
Kallies, A., and Nutt, S.L. (2007). Terminal differentiation of lymphocytes
depends on Blimp-1. Curr. Opin. Immunol. 19, 156–162.
Kallies, A., Hasbold, J., Tarlinton, D.M., Dietrich, W., Corcoran, L.M., Hodgkin,
P.D., and Nutt, S.L. (2004). Plasma cell ontogeny defined by quantitative
changes in blimp-1 expression. J. Exp. Med. 200, 967–977.
Kallies, A., Hawkins, E.D., Belz, G.T., Metcalf, D., Hommel, M., Corcoran, L.M.,
Hodgkin, P.D., and Nutt, S.L. (2006). Transcriptional repressor Blimp-1 is
essential for T cell homeostasis and self-tolerance. Nat. Immunol. 7, 466–474.
Kallies, A., Hasbold, J., Fairfax, K., Pridans, C., Emslie, D., McKenzie, B.S.,
Lew, A.M., Corcoran, L.M., Hodgkin, P.D., Tarlinton, D.M., and Nutt, S.L.
(2007). Initiation of plasma-cell differentiation is independent of the transcrip-
tion factor Blimp-1. Immunity 26, 555–566.
Kohlmeier, J.E., Miller, S.C., Smith, J., Lu, B., Gerard, C., Cookenham, T., Rob-
erts, A.D., and Woodland, D.L. (2008). The chemokine receptor CCR5 plays
a key role in the early memory CD8+ T cell response to respiratory virus infec-
tions. Immunity 29, 101–113.
Lyons, A.B., and Parish, C.R. (1994). Determination of lymphocyte division by
flow cytometry. J. Immunol. Methods 171, 131–137.
Magnusdottir, E., Kalachikov, S., Mizukoshi, K., Savitsky, D., Ishida-Yama-
moto, A., Panteleyev, A.A., and Calame, K. (2007). Epidermal terminal differen-
tiation depends on B lymphocyte-induced maturation protein-1. Proc. Natl.
Acad. Sci. USA 104, 14988–14993.
Martins, G., and Calame, K. (2008). Regulation and functions of Blimp-1 in T
and B lymphocytes. Annu. Rev. Immunol. 26, 133–169.
Martins, G.A., Cimmino, L., Shapiro-Shelef, M., Szabolcs, M., Herron, A., Mag-
nusdottir, E., and Calame, K. (2006). Transcriptional repressor Blimp-1 regu-
lates T cell homeostasis and function. Nat. Immunol. 7, 457–465.
Martins, G.A., Cimmino, L., Liao, J., Magnusdottir, E., and Calame, K. (2008).
Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell prolif-
eration and survival. J. Exp. Med. 205, 1959–1965.
Masopust, D., Kaech, S.M., Wherry, E.J., and Ahmed, R. (2004). The role of
programming in memory T-cell development. Curr. Opin. Immunol. 16,
217–225.
Nutt, S.L., Fairfax, K.A., and Kallies, A. (2007). BLIMP1 guides the fate of
effector B and T cells. Nat. Rev. Immunol. 7, 923–927.
Ohinata, Y., Payer, B., O’Carroll, D., Ancelin, K., Ono, Y., Sano, M., Barton,
S.C., Obukhanych, T., Nussenzweig, M., Tarakhovsky, A., et al. (2005).
Blimp-1 is a critical determinant of the germ cell lineage in mice. Nature 436,
207–213.
Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S.,
Zediak, V.P., Banica, M., DiCioccio, C.B., Gross, D.A., Mao, C.A., et al.
(2003). Control of effector CD8+ T cell function by the transcription factor Eo-
mesodermin. Science 302, 1041–1043.
Robertson, E.J., Charatsi, I., Joyner, C.J., Koonce, C.H., Morgan,M., Islam, A.,
Paterson, C., Lejsek, E., Arnold, S.J., Kallies, A., et al. (2007). Blimp-1 regulates
Immunity
Blimp-1 Is Required for Effector CD8+ T Cellsdevelopment of the posterior forelimb, caudal pharyngeal arches, heart and
sensory vibrissae in mice. Development 134, 4335–4345.
Santer-Nanan, B., Berberich-Siebelt, F., Xiao, Z., Poser, N., Sennefelder, H.,
Rauthe, S., Vallabhapurapu, D.S., Berberich, I., Schimpl, A., Kreth, H.W.,
andNanan, R. (2006). Blimp-1 is expressed in human andmouse T cell subsets
and leads to loss of IL-2 production and to defective proliferation. Signal
Transduct. 6, 268–279.
Sprent, J., and Surh, C.D. (2002). T cell memory. Annu. Rev. Immunol. 20,
551–579.
Takemoto, N., Intlekofer, A.M., Northrup, J.T., Wherry, E.J., and Reiner, S.L.
(2006). Cutting edge: IL-12 inversely regulates T-bet and eomesodermin
expression during pathogen-induced CD8+ T cell differentiation. J. Immunol.
177, 7515–7519.Teixeiro, E., Daniels, M.A., Hamilton, S.E., Schrum, A.G., Bragado, R.,
Jameson, S.C., and Palmer, E. (2009). Different T cell receptor signals deter-
mine CD8+ memory versus effector development. Science 323, 502–505.
Townsend, A.R., Gotch, F.M., and Davey, J. (1985). Cytotoxic T cells recognize
fragments of the influenza nucleoprotein. Cell 42, 457–467.
Wherry, E.J., Teichgraber, V., Becker, T.C., Masopust, D., Kaech, S.M., Antia,
R., von Andrian, U.H., and Ahmed, R. (2003). Lineage relationship and protec-
tive immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225–234.
Williams, M.A., and Bevan, M.J. (2007). Effector and memory CTL differentia-
tion. Annu. Rev. Immunol. 25, 171–192.
Williams, M.A., Tyznik, A.J., and Bevan, M.J. (2006). Interleukin-2 signals
during priming are required for secondary expansion of CD8+ memory
T cells. Nature 441, 890–893.Immunity 31, 283–295, August 21, 2009 ª2009 Elsevier Inc. 295
